Volume and heat capacity studies to evidence interactions between cyclodextrins and nicotinic acid in water

被引:0
|
作者
Irina V. Terekhova
Rosario De Lisi
G. Lazzara
Stefania Milioto
Nicola Muratore
机构
[1] Institute of Solution Chemistry of Russian Academy of Sciences,Dipartimento di Chimica Fisica ‘F. Accascina’
[2] Università degli Studi di Palermo,undefined
[3] Viale delle Scienze,undefined
[4] Parco D’Orleans II,undefined
关键词
apparent molar heat capacity; apparent molar volume; cyclodextrin; inclusion complex formation; nicotinic acid;
D O I
暂无
中图分类号
学科分类号
摘要
Density and heat capacity of the water+cyclodextrin (CD), water+nicotinic acid (NA) and water+CD+NA mixtures were determined at 298.15 K. CDs with different cavity size and alkylation were selected. From the experimental data the apparent molar properties were calculated. Assuming the formation of inclusion complexes of 1:1 stoichiometry, these properties were modeled and provided the stability constants of CD/NA inclusion complexes and the corresponding property change. The binding of NA with the smallest sized α-cyclodextrin (α-CD) generates more stable complexes accompanied by the lower volume and the heat capacity changes. These results are in agreement with earlier proposed binding mode according to which deep insertion of NA into α-CD takes place and it is governed by the hydrophobic-hydrophilic forces. The volume and the heat capacity changes caused by the interactions of CDs with NA were interpreted in terms of cosphere overlap model and the release of water molecules from the CD cavity due to the NA incorporation.
引用
收藏
页码:285 / 290
页数:5
相关论文
共 50 条
  • [41] Heat-induced and concentration-dependent interactions between β-conglycinin and chlorogenic acid: Implications for protein stability, chlorogenic acid bioaccessibility, and antioxidant capacity
    Qie, Xuejiao
    Wu, Yaru
    Chen, Wenpu
    Bu, Xiaotong
    Wang, Zhaojun
    Chen, Qiuming
    Zeng, Maomao
    Chen, Jie
    Goff, H. Douglas
    He, Zhiyong
    FOOD BIOSCIENCE, 2024, 62
  • [42] Interactions Between Humic Acid and the Forms and Bioavailability of Copper in Water
    Pan, Hongwei
    Shi, Lili
    Liu, Xin
    Lei, Hongjun
    Yang, Guang
    Chen, Huiru
    WATER AIR AND SOIL POLLUTION, 2023, 234 (05):
  • [43] Interactions Between Humic Acid and the Forms and Bioavailability of Copper in Water
    Hongwei Pan
    Lili Shi
    Xin Liu
    Hongjun Lei
    Guang Yang
    Huiru Chen
    Water, Air, & Soil Pollution, 2023, 234
  • [44] A computational study of interactions between acetic acid and water molecules
    Yamabe, S
    Tsuchida, N
    JOURNAL OF COMPUTATIONAL CHEMISTRY, 2003, 24 (08) : 939 - 947
  • [45] SHEAR VISCOSITY, HEAT-CAPACITY, AND FLUCTUATIONS OF LIQUID WATER, ALL AT CONSTANT MOLAL VOLUME
    WALRAFEN, GE
    CHU, YC
    JOURNAL OF PHYSICAL CHEMISTRY, 1991, 95 (22): : 8909 - 8921
  • [46] Binding of d-tubocurarine analogs to the nicotinic acetylcholine receptor (AChR): Evidence for specific amino acid interactions
    Papineni, RVL
    Pedersen, SE
    BIOPHYSICAL JOURNAL, 1997, 72 (02) : TUP66 - TUP66
  • [47] Exploring drug-protein interactions using the relationship between injection volume and capacity factor
    Zhao, Xinfeng
    Li, Qian
    Chen, Jiejun
    Xiao, Chaoni
    Bian, Liujiao
    Zheng, Jianbin
    Zheng, Xiaohui
    Li, Zijian
    Zhang, Youyi
    JOURNAL OF CHROMATOGRAPHY A, 2014, 1339 : 137 - 144
  • [48] Lipid-protein interactions at the nicotinic acetylcholine receptor - A functional coupling between nicotinic receptors and phosphatidic acid-containing lipid bilayers
    daCosta, CJB
    Ogrel, AA
    McCardy, EA
    Blanton, MP
    Baenziger, JE
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) : 201 - 208
  • [49] Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid
    Yan Rong
    Tony Kiang
    Clinical Pharmacokinetics, 2023, 62 : 157 - 207
  • [50] Clinical Evidence on the Purported Pharmacokinetic Interactions between Corticosteroids and Mycophenolic Acid
    Rong, Yan
    Kiang, Tony
    CLINICAL PHARMACOKINETICS, 2023, 62 (02) : 157 - 207